Does DABRAFENIB Cause Ejection fraction decreased? 214 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 214 reports of Ejection fraction decreased have been filed in association with DABRAFENIB (Tafinlar). This represents 1.1% of all adverse event reports for DABRAFENIB.
214
Reports of Ejection fraction decreased with DABRAFENIB
1.1%
of all DABRAFENIB reports
17
Deaths
82
Hospitalizations
How Dangerous Is Ejection fraction decreased From DABRAFENIB?
Of the 214 reports, 17 (7.9%) resulted in death, 82 (38.3%) required hospitalization, and 8 (3.7%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 214 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which DABRAFENIB Alternatives Have Lower Ejection fraction decreased Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB